Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
Authors:
- Tugba Mehmetoglu-GurbuzTMTugba Mehmetoglu-Gurbuz
- Rajkumar LakshmanaswamyRLRajkumar Lakshmanaswamy
- Karla PerezKPKarla Perez
- Mayra SandovalMSMayra Sandoval
- Casandra A. JimenezCJCasandra A. Jimenez
- Jackelyn RochaJRJackelyn Rocha
- Rachel Madeline GoldfarbRGRachel Madeline Goldfarb
- Courtney PerryCPCourtney Perry
- Alejandra BencomoABAlejandra Bencomo
- Nishkala NeelaNNNishkala Neela
- Jose A. BarraganJBJose A. Barragan
- Raquel SanchezRSRaquel Sanchez
Open Access
- 22 September 2023
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 12 (10) , 1791
Abstract
Reactive oxygen species are frequently associated with various cancers including pancreatic ductal adenocarcinomas (PDACs). Superoxide dismutase 2 (SOD2) is an enzyme that plays an important role in reactive oxygen species (ROS) signaling. Investigating the molecular function and biological functions of SOD2 can help us develop new therapeutic options and uncover new biomarkers for PDAC diagnosis and prognosis. Here, we show that nimbolide (NB), a triterpene limonoid, effectively blocks the growth and metastasis of PDACs by suppressing the expression and activity of SOD2. To identify the role of SOD2 in NB-induced anticancer activity, we used RNA interference to silence and plasmid transfection to overexpress it. Silencing SOD2 significantly reduced the growth and metastatic characteristics like epithelial-to-mesenchymal transition, invasion, migration, and colony-forming capabilities of PDACs, and NB treatment further reduced these characteristics. Conversely, the overexpression of SOD2 enhanced these metastatic characteristics. ROS signaling has a strong feedback mechanism with the PI3K/Akt signaling pathway, which could be mediated through SOD2. Finally, NB treatment to SOD2-overexpressing PDAC xenografts resulted in significant inhibition of tumor growth and metastasis. Overall, this work suggests that NB, a natural and safe phytochemical that silences SOD2 to induce high levels of ROS generation, results in increased apoptosis and reduced growth and progression of PDACs. The role of SOD2 in regulating NB-induced ROS generation presents itself as a therapeutic option for PDACs.Keywords
This publication has 43 references indexed in Scilit:
- Treatment with Azadirachta indica in diabetic pregnant rats: Negative effects on maternal outcomeJournal of Ethnopharmacology, 2012
- Impact of Curcumin, Raspberry Extract, and Neem Leaf Extract on Rel Protein-Regulated Cell Death/Radiosensitization in Pancreatic Cancer CellsPancreas, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Redox Control of Vascular Smooth Muscle MigrationAntioxidants & Redox Signaling, 2010
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- The use of neem for controlling gastric hyperacidity and ulcerPhytotherapy Research, 2009
- Reactive oxygen species: A double-edged sword in oncogenesisWorld Journal of Gastroenterology, 2009
- An antimalarial extract from neem leaves is antiretroviralTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004
- Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticideLife Sciences, 1996